GNAS is a complex gene that through use of alternative fi rst exons encodes signaling proteins Gα s and XLαs plus neurosecretory protein NESP55. Tissue-specifi c expression of these proteins is regulated through reciprocal genomic imprinting in fully differentiated and developed tissue. Mutations in GNAS account for several human disorders, including McCune-Albright syndrome and Albright hereditary osteodystrophy, and further knowledge of GNAS imprinting may provide insights into variable phenotypes of these disorders. We therefore analyzed expression of Gα s , NESP55, and XLαs prior to tissue differentiation in cell cultures derived from human primordial germ cells. We found that the expression of Gα s was biallelic (maternal allele: 52.6% ± 2.5%; paternal allele: 47.2% ± 2.5%; p = 0.07), whereas NESP55 was expressed preferentially from the maternal allele (maternal allele: 81.9% ± 10%; paternal allele: 18.1% ± 10%; p = 0.002) and XLαs was preferentially expressed from the paternal allele (maternal allele: 2.7% ± 0.3%; paternal allele: 97.3% ± 0.3%; p = 0.007). These results demonstrate that imprinting of NESP55 occurs very early in development, although complete imprinting appears to take place later than 5-11 weeks postfertilization, and that imprinting of XLαs occurs very early postfertilization. By contrast, imprinting of Gα s most likely occurs after 11 weeks postfertilization and after tissue differentiation.
Introduction
Genomic imprinting is an epigenetic process whereby one allele undergoes a partial or total loss of expression. 1 Most commonly, imprints are established during gametogenesis. Aft er fertilization, these epigenetic markers are maintained as chromosomes duplicate and separate in the developing organism. 1 Th e associated patterns of imprinting are also oft en both tissue and developmental-stage specifi c, and the silencing is only partial. 2 Imprinting may cause disease if disrupted and if allelic transcription is either activated or suppressed inappropriately. Abnormal imprinting may be secondary to changes in methylation, histone tail modifi cations, or by disruptions in chromatin binding. 3 In the absence of an imprinting defect, the phenomenon of imprinting can lead to unusual, non-Mendelian patterns of inheritance that introduce parental origin eff ects on the phenotype.
Th e GNAS locus, located at chromosome 20q13.3, 4 exhibits a complex pattern of reciprocal genomic imprinting (Figure 1) , 5, 6 with fi ve alternative promoters that generate multiple sense and antisense transcripts. Transcripts that encode Gα s , the alpha chain of the heterotrimeric guanine nucleotide binding protein that couples hepatahelical receptors to stimulation of adenylyl cyclase, are derived from exons 1-13. Gα s was initially shown to be paternally imprinted in a tissue-specifi c manner through studies of murine models. [7] [8] [9] Th e tissue-specifi c imprinting was subsequently found to be partial in the renal cortex, thyroid, pituitary, and ovaries from studies of both murine and human tissue. [7] [8] [9] [10] [11] [12] [13] Upstream of exon 1 are three alternative fi rst exons that each splice onto exons 2-13 to create novel sense transcripts ( Figure 1 ). XLαs encodes a signaling protein that stimulates adenylyl cyclase but lacks a known receptor and has been shown to be maternally imprinted (paternally expressed). 14, 15 NESP55 encodes a secretory protein and has been shown to be paternally imprinted (maternally expressed). [16] [17] [18] [19] Exon 1A (also termed as exon A/B) does not encode a known protein but the transcript has been shown to be maternally imprinted (paternally expressed). 6, [20] [21] [22] Th e mechanism of imprinting of these three alternative transcripts is via diff erentially methylated regions (DMRs) in their respective promoter regions, whereas tissuespecifi c imprinting of exon 1 depends upon the methylation status of the DMR for exon 1A. 6, 16, 17, 21, [23] [24] [25] Heterozygous GNAS mutations that alter function or expression of Gα s are associated with several human disorders and the phenotypes are infl uenced by a parent of origin eff ect that refl ects predominant expression of Gα s from maternal alleles in certain tissues. Loss of function mutations causes an unusual constellation of somatic defects termed as Albright hereditary osteodystrophy (AHO), which includes short stature, subcutaneous ossifi cations, brachydactyly, and dental abnormalities. When a GNAS mutation occurs on the maternally inherited allele, AHO is associated with resistance to multiple hormones, such as PTH, TSH, GHRH, and gonadotropins, as well as obesity 26 and cognitive defects. 27 Th is condition is termed as pseudohypoparathyroidism (PHP) type 1a. In contrast, when the GNAS mutations occur on the paternally inherited allele, only the AHO features are present, a condition termed as pseudopseudohypoparathyroidism (pseudoPHP). 26, [28] [29] [30] [31] [32] [33] [34] [35] Mutations that abrogate normal methylation of the exon 1A DMR on the maternal allele suppress maternal expression of Gα s in hormone-target tissues, leading to an isolated form of PTH resistance termed as PHP type 1b. 25 Gain of function mutations in GNAS is also implicated as the basis of human disease. Missense mutations of Arg201 or Gln227 that lead to constitutive activation of Gα s cause isolated endocrine tumors or McCune-Albright syndrome, a disorder characterized by autonomous function and proliferation of endocrine tissues, fi brous dysplasia, and pigmented café au lait skin lesions. Th e clinical presentation can be aff ected by the parent of origin of the mutated allele because Gα s is imprinted and expressed specifi cally by the maternal allele in certain tissues. [23] [24] [25] Th e ontogeny and regulation of GNAS imprinting during development are still incompletely understood. Studies in the mouse have shown that the Nespas-Gnasxl DMR is a gametic imprint, 36 which together with the earlier identifi cation of a germ line DMR at Gnas exon 1A, 21 predicts that the locus could contain two imprint control regions (ICRs) and is divided between separate domains regulated by independent imprinting mechanisms. Support for this hypothesis derives from imprinting anomalies of human GNAS encountered in the disorder PHP type 1b. 6, 25 Similar studies that have examined human imprinting as early as 6 to 13 weeks of fetal development in diff erentiated tissues, specifi cally heart, spinal cord, muscle, kidney, lung, gut, eye, brain, adrenal, stomach, and ovaries showed expression of Gα s to be biallelic, whereas expression of XLαs and NESP55 was monoallelic. 16, 17, 37 However, these studies were imprecise as the techniques used to assess the parental origin of Gα s transcripts also included the amplifi cation of XLαs and NESP55 transcripts. Recent studies in sheep revealed that GNAS was maternally expressed in the fetus but paternally expressed in the chorioallantois at day 21. 38 Studies in human embryonic stem (hES) cells demonstrated imprinting of NESP55 with some expression from the paternal allele. 39 In order to further elucidate the timing of imprinting of Gα s and XLαs, as well as confi rm early imprinting of NESP55, we examined cell cultures derived from primordial germ cells. Primordial germ cells obtained from the gonadal ridges and attached mesenteries of 5 to 11 week postfertilization male and female embryos were used to derive pluripotent embryonic germ (EG) cell lines. 40 EG cells diff erentiate by forming complex threedimensional cell aggregates termed as embryoid bodies (EBs), which may contain pluripotent stem cells and cells in various stages of diff erentiation. Th e cultured cell lines derived from EBs, embryoid body-derived cells (EBDs), proliferate robustly with a normal karyotype and contain precursors and progenitor cells of various lineages. 41 Th e EG cells have the ability to form all three germ layers and therefore potentially all the organs of the body, and thus are considered a good model for hES cells.
In all EBD cell lines that we examined, the expression of Gα s was biallelic whereas expression of NESP55 and XLαs was preferentially from the maternal or paternal allele, respectively. Th ese results strongly imply that the tissue-specifi c imprinting of Gα s occurs aft er 11 weeks postfertilization and aft er tissue differentiation; the imprinting of XLαs occurs very early postfertilization. In addition, these data are consistent with the prior fi ndings that imprinting of NESP55 in ES cell lines occurs very early in development, although complete imprinting takes place later than 5-11 weeks postfertilization. 39
Materials and Methods
EBD cell cultures (LVEE, SLRC, BBEP, SCEC, EDEC, CDEP, and EUEE) were cultured and maintained under conditions as previously described. 40 Th e karyotypes of LVEE were 46XX and of SLRC were 46XY. RNA was isolated using an RNA isolation kit with modified cultured cell protocol (Gentra Systems, Minneapolis, MN, USA). First strand cDNA was synthesized as previously described with appropriate controls. 10 NESP55, XLαs, and Gα s PCR products were amplifi ed using specifi c forward primers corresponding to nucleotide sequences in the fi rst exon for each and a common reverse primer corresponding to nucleotide sequences in exon 6, 8, and 13 ( Table 1) . To further amplify PCR products from NESP55 and XLαs, nested PCR was performed aft er DNA was purifi ed from the initial PCR product (Qiagen, Valencia, CA, USA) ( Table 1) . Aft er PCR, 30 μL samples were electrophoresed in 1.5% agarose gels, stained with ethidium bromide, and appropriate sized bands were isolated. Reactions without reverse transcriptase and without RNA produced no bands. DNA from the PCR products was extracted using QIAquick gel extraction kit (Qiagen). DNA fragments were sequenced and analyzed by phosphoimager quantitation, calculating for percent expression of uniallelic bands minus background as previously described. 10 Data are expressed as mean ± SEM. Statistical signifi cance between groups was determined using unpaired t test with diff erences considered signifi cant at p < 0.05.
Results and Discussion
Nearly 100 genes in the human and mouse genomes are imprinted and are therefore monoallelically expressed in a tissue and developmental stage-specifi c manner (http://www.mgu.har.mrc. ac.uk/research/genomic_imprinting/maps.html). 42 Abnormal imprinting of many of these genes results in either anomalous activation or suppression of transcription that leads to a variety of clinical consequences, including abnormal fetal growth, disturbances in neurocognitive development, and neoplasia. 43, 44 In the present study, we assessed allelic expression of GNAS transcripts in seven diff erent cell cultures (LVEE, SLRC, BBEP, SCEC, EDEC, CDEP, and EUEE) using single nucleotide polymorphisms (SNPs) within exons 5, 7, and 13 of GNAS to distinguish between parent of origin of transcripts. [45] [46] [47] Some cell lines were also examined under culture conditions to ensure reproducibility regardless of external factors (LVEE and LVEC). Five of the seven cell lines were informative as there was heterozygosity for at least one of the three GNAS SNPs. Two cell lines (LVEE and SLRC) were heterozygous for the exon 5 SNP (Figure 2A) , three cell lines (BBEP, EDEC, and SCEC) were heterozygous for the exon 7 SNP ( Figure 2B) , and three cell lines (BBEP, EDEC, and SCEC) were heterozygous for the exon 13 SNP (data not shown). Gα s transcripts were derived equally from the maternal (52.6% ± 2.5% of total, range: 48.7% to 55.2%) and paternal (47.2% ± 2.6% of total, range: 44.8% to 51.3%) alleles (p = 0.07). By contrast, for all fi ve cell cultures, NESP55 was preferentially expressed from the maternal allele (81.9% ± 10% of total, range: 69.6% to 95.3%), with only a minor contribution derived from the paternal allele (18.1% ± 10%, range: 4.7% to 30.4%) (p = 0.002) (Figure 3) . We were only able to amplify XLαs through the exon 5 polymorphism, and thus were limited to two samples for analysis, which showed 97.3% ± 0.3% (range: 96.8% to 97.8%) expression from the paternal allele and 2.7% ± 0.3% (range: 2.2% to 3.2%) expression from the maternal allele (p = 0.007).
In the cell lines examined, expression of the imprinted NESP55 allele was greater (18%) than the imprinted XLαs allele (3%). Th ese results are consistent with the report by Rugg-Gunn et al., in which the expression of NESP55 in human ES cells was generally monoallelic but did have random low expression of the imprinted paternal allele (approximately 20% in 2 of 5 cells examined). 48 Th ese results are in contrast to similar analyses performed in adult tissues, in which expression of both NESP55 and XLαs appears to be uniallelic. [8] [9] [10] [11] [12] [13] One explanation for this discrepancy is that imprinting of GNAS, as for some other genes, 49 in mice some imprinted genes, including Snrpn and H19, are initially monoallelically expressed postfertilization, then become demethylated and biallelically expressed later in gestation. [50] [51] [52] [53] However, studies in humans have found that the imprinting of Snrpn may only become established in early postzygotic development. 54 Further analyses of H19 in mice have shown that the methylation of the promoter-proximal region of H19 was erased during preimplantation development and reestablished by midgestation, but the methylation of the distal region was preserved throughout embryogenesis. 55 By contrast, Rugg-Gunn found that the H19 promoter was differentially methylated in hESCs. 48 Our current results extend these interspecies discrepancies to GNAS. In mice, the DMR of Nesp is not established until postimplantation development after the blastocyst stage, and the DMR of Gnasxl is partially methylated in both sperm and oocytes, indicating either that methylation of the maternal allele is not erased in the germ cells or that methylation occurs de novo in these cells. 56 By contrast, we found that imprinting of NESP55 is not yet complete whereas XLαs imprinting is essentially complete prior to tissue diff erentiation. This study is unique in that expression of Gα s , NESP55, and XLαs is evaluated individually and prior to tissue diff erentiation in a unique model, EBD cell cultures. Th us, we overcame the limitations of a previous study of Gα s expression in fetal tissues that was confounded by use of primers that amplifi ed all transcripts from the GNAS locus. 37 Moreover, EBD cell cultures represent a homogenous population of cells and avoid artifacts introduced using tissues that contain heterogenous populations of cells that may have diff erent patterns of imprinting. EBD cell cultures have been shown to express simultaneously a wide array of mRNA and protein markers that are normally associated with distinct developmental lineages. In addition, these cells are able to diff erentiate in vitro into derivatives of the three embryonic germ layers, and thus meet the defi nition of pluripotent stem cells. Although EBD cells are not identical to hES cells, it is important to note that they appear to have comparable epigenetic stability based on analyses showing similar imprinting patterns for IGF2. 57 Our study has several limitations. First, we were unable to assess expression of exon 1A alleles. Biallelic expression of Gα s in EBD cell cultures could indicate transient methylation of the paternal exon 1A DMR, or more likely, lack of expression of a putative repressor protein that has been proposed to silence transcription of Gα s from the paternal allele in imprinted tissues. [23] [24] [25] Second, we did not directly assess methylation status of the DMRs corresponding to NESP, XLαs, and exon 1A ICRs. Finally, because EBD cell cultures contain precursors of various cell lineages, our studies do not necessarily refl ect in vivo timing of tissue-specifi c imprinting of the various gene products nor do they address what occurs in vivo in somatic tissues. Nevertheless, our results further support the hypothesis that Gα s is biallelically expressed in early embryonic development and becomes imprinted aft er 11 weeks postfertilization and aft er tissue diff erentiation. In addition, we have confi rmed early imprinting in NESP55 in these Quantifi cation of band intensity of the polymorphic alleles was performed with the Phosphorimager system (Bio-Rad, Hercules, CA, USA) and corrected for variability of sample loading between lanes. In all fi ve cell cultures heterozygous for the exon 5, 7, or 13 polymorphism, the expression of Gα s was biallelic (maternal allele = 52.6% ± 2.5%; paternal allele = 47.2% ± 2.5%; p = 0.07), whereas NESP55 was expressed preferentially from the maternal allele (maternal allele = 81.9% ± 10%; paternal allele = 18.1% ± 10%; p = 0.002) and XLαs was preferentially expressed from the paternal allele (maternal allele = 2.7% ± 0.3%; paternal allele = 97.3% ± 0.3%; p = 0.007). Error bars indicate SEM.
human embryonic germ cell cultures as found in ES cell lines by others, 39 although complete imprinting takes place later than 5-11 weeks postfertilization. Finally, we have demonstrated that XLαs is imprinted as early as 5-11 weeks postfertilization in human embryonic germ cell cultures. Knowledge regarding the timing of GNAS imprinting may provide further clues regarding the causes of the variable phenotypes associated with mutations in this gene.
